Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Breast cancer prevention targets

11th Milan Breast Cancer Conference 2009

17 - 19 Jun 2009

Published: 15 Jul 2009

Views: 3368

Rating:

Save

Dr Karen Johnson - National Cancer Institute, USA

Dr Karen Johnson - National Cancer Institute, USA, speaking at the 11th Milan Breast Cancer Conference: Increasing efficiency with small trials for breast cancer prevention. Targeting the oestrogen receptor. PARP inhibtors. HER2/neu.

Categories:
Breast

Related Videos

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...

Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )

Exercise positively effects symptom burden and quality of life of metastatic...

Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients ( Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands )

Using AI to identify patients at increased risk of side effects from radiation...

Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )

Implementation of the Choosing Wisely Africa List in 3 Countries

Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania

Implementation of the Choosing Wisely Africa List in 3 Countries ( Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania )

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...

Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )

T-DM1 shows promise in treating unresectable locally advanced or metastatic...

Dr Sara Hurvitz - University of Washington, Seattle, USA

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer ( Dr Sara Hurvitz - University of Washington, Seattle, USA )

ASCO and its Sub-Saharan African outreach programme

Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology...

ASCO and its Sub-Saharan African outreach programme ( Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology (ASCO), USA )

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer

Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer ( Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya )

More from ecancer